Securities Code: 301234 Securities Abbreviation: Wuzhou Medical Announcement No.: 2026-032
Anhui Hongyu Wuzhou Medical Devices Co., Ltd.
Announcement on Abnormal Stock Trading Fluctuations
The Company and the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.
Special Reminder:
-
Anhui Hongyu Wuzhou Medical Devices Co., Ltd. (hereinafter referred to as the "Company") stock has experienced an abnormal trading fluctuation, with the cumulative increase in closing price deviation reaching 30.22% (exceeding 30%) over two consecutive trading days (August 7, 2026, and August 10, 2026), in accordance with the "Trading Rules of the Shenzhen Stock Exchange."
-
As of August 10, 2026, according to the latest data from Wind Information, the rolling P/E ratio for the industry category "C35101020 Medical Consumables" to which the Company belongs is 33.53 times, and the static P/E ratio is 32.39 times. As of August 10, 2026, the Company's dynamic P/E ratio is 194.03 times, and the static P/E ratio is 330.73 times. The Company's P/E ratio is significantly higher than the average level of "C35101020 Medical Consumables."
-
The Company has scheduled the disclosure of its "2026 Semi-Annual Report" on August 24, 2026, and the relevant preparation work is currently underway. In accordance with the requirements of the "Listing Rules of the Shenzhen Stock Exchange ChiNext Board," the Company does not need to disclose a performance forecast. As of the date of this announcement, the Company has not provided any third party with performance-related information for the first half of 2026.
-
The Company is primarily engaged in the research, development, manufacturing, and sales of disposable sterile infusion medical devices, as well as the integrated supply of other diagnostic, nursing, and related medical products. After self-examination, the Company's current production and operation activities are normal. Apart from the information already disclosed, there have been no significant changes in the Company's operating conditions or the internal and external business environment recently. The Company urges investors to invest rationally and be aware of investment risks.